Alpha Tau Medical Ltd. DRTSW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

There have been 50 recent insider transactions recorded for Alpha Tau Medical Ltd. (DRTSW), including 0 buys and 0 sells.

Notable insiders with recent activity include Levy Raphi, Milch David Mark, Kidron Nadav. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — DRTSW

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2026-04-01	Levy Raphi	Chief Financial Officer	Unknown	158,882	$6.41	$1.02M	-
2026-03-18	Milch David Mark	Director	Unknown	49,000	$11.50	$563.5K	-
2026-03-18	Kidron Nadav	Director	Unknown	15,527	$6.41	$99.53K	-
2026-03-18	Blumenfeld S Morry	Director	Unknown	15,527	$6.41	$99.53K	-
2026-03-18	Alon Ruth	Director	Unknown	15,527	$6.41	$99.53K	-
2026-03-18	Avruch Michael	Director	Unknown	15,527	$6.41	$99.53K	-
2026-03-18	Sofer Uzi	Chief Executive Officer	Unknown	396,680	$7.32	$2.9M	-
2026-03-18	Adler Alan	Director	Unknown	15,527	$6.41	$99.53K	-
2026-03-18	Levy Raphi	Chief Financial Officer	Unknown	-	-	-	23,996
2026-03-18	Netser Maya	Director	Unknown	15,527	$6.41	$99.53K	-
2025-06-17	Milch David Mark	Director	Unknown	24,460	$4.05	$99.06K	-
2025-06-17	Blumenfeld S Morry	Director	Unknown	24,460	$4.05	$99.06K	-
2025-06-17	Alon Ruth	Director	Unknown	24,460	$4.05	$99.06K	-
2025-06-17	Avruch Michael	Director	Unknown	24,460	$4.05	$99.06K	-
2025-06-17	Sofer Uzi	Chief Executive Officer	Unknown	24,460	$4.05	$99.06K	-
2025-06-17	Adler Alan	Director	Unknown	24,460	$4.05	$99.06K	-
2025-06-12	Kidron Nadav	Director	Unknown	35,554	$2.79	$99.2K	-
2025-04-01	Sofer Uzi	Chief Executive Officer	Unknown	674,238	$3.07	$2.07M	-
2025-04-01	Levy Raphi	Chief Financial Officer	Unknown	267,641	$2.60	$695.87K	-
2025-01-17	Netser Maya	Director	Unknown	24,048	$4.05	$97.39K	-
2024-12-17	Milch David Mark	Director	Unknown	43,257	$2.98	$128.91K	-
2024-12-17	Blumenfeld S Morry	Director	Unknown	43,257	$2.98	$128.91K	-
2024-12-17	Alon Ruth	Director	Unknown	43,257	$2.98	$128.91K	-
2024-12-17	Avruch Michael	Director	Unknown	43,257	$2.98	$128.91K	-
2024-12-17	Sofer Uzi	Chief Executive Officer	Unknown	43,257	$2.98	$128.91K	-
2024-12-17	Adler Alan	Director	Unknown	43,257	$2.98	$128.91K	-
2024-04-01	Sofer Uzi	Chief Executive Officer	Unknown	763,843	$3.48	$2.66M	-
2024-04-01	Levy Raphi	Chief Financial Officer	Unknown	301,880	$2.98	$899.6K	-
2024-01-01	Blumenfeld S Morry	Director	Unknown	46,905	$3.28	$153.85K	-
2024-01-01	Avruch Michael	Director	Unknown	46,905	$3.28	$153.85K	-
2024-01-01	Sofer Uzi	Chief Executive Officer	Unknown	46,905	$3.28	$153.85K	-
2024-01-01	Adler Alan	Director	Unknown	46,905	$3.28	$153.85K	-
2023-11-01	Milch David Mark	Director	Unknown	46,905	$3.28	$153.85K	-
2023-11-01	Alon Ruth	Director	Unknown	46,905	$3.28	$153.85K	-
2023-04-01	Sofer Uzi	Chief Executive Officer	Unknown	1,102,653	$3.57	$3.94M	-
2023-04-01	Levy Raphi	Chief Financial Officer	Unknown	328,458	$3.28	$1.08M	-
2022-11-02	Blumenfeld S Morry	Director	Unknown	10,657	$7.19	$76.62K	-
2022-11-02	Avruch Michael	Director	Unknown	10,657	$7.19	$76.62K	-
2022-11-02	Adler Alan	Director	Unknown	10,657	$7.19	$76.62K	-
2022-06-07	Blumenfeld S Morry	Director	Unknown	24,727	$11.50	$284.36K	-
2022-06-07	Avruch Michael	Director	Unknown	24,727	$11.50	$284.36K	-
2022-06-07	Sofer Uzi	Chief Executive Officer	Unknown	250,933	$7.19	$1.8M	-
2022-06-07	Adler Alan	Director	Unknown	24,727	$11.50	$284.36K	-
2022-06-07	Levy Raphi	Chief Financial Officer	Unknown	80,360	$7.19	$577.79K	-
2022-04-21	Alon Ruth	Director	Unknown	10,178	$7.19	$73.18K	-
2022-04-07	Milch David Mark	Director	Unknown	10,178	$7.19	$73.18K	-
2022-03-07	Levy Raphi	Chief Financial Officer	Unknown	90,529	$4.03	$364.83K	-
2020-09-03	Levy Raphi	Chief Financial Officer	Unknown	45,265	$4.42	$200.07K	-
2019-03-01	Blumenfeld S Morry	Director	Unknown	54,318	$4.42	$240.09K	-
2019-03-01	Avruch Michael	Director	Unknown	54,318	$4.42	$240.09K	-

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry